We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PULM icon
5251
Pulmatrix
PULM
$6.1M
$15 ﹤0.01%
+3
New +$16
CFSB
5252
DELISTED
CFSB Bancorp
CFSB
$14 ﹤0.01%
+1
New +$14
EDSA icon
5253
Edesa Biotech
EDSA
$51.6M
$14 ﹤0.01%
+6
New +$14
REFR icon
5254
Research Frontiers
REFR
$13.6M
$14 ﹤0.01%
+9
New +$14
RDI icon
5255
Reading International Class A
RDI
$32.5M
$13 ﹤0.01%
+9
New +$13
VANI icon
5256
Vivani Medical
VANI
$109M
$13 ﹤0.01%
+9
New +$12
WFCF icon
5257
Where Food Comes From
WFCF
$60.5M
$13 ﹤0.01%
+1
New +$12
CYCN icon
5258
Cyclerion Therapeutics
CYCN
$15.2M
$12 ﹤0.01%
+5
New +$14
MITQ icon
5259
Moving iMage Technologies
MITQ
$5.32M
$12 ﹤0.01%
+13
New +$11
NAII icon
5260
Natural Alternatives International
NAII
$13.9M
$12 ﹤0.01%
+4
New +$14
NSTS icon
5261
NSTS Bancorp
NSTS
$66.7M
$12 ﹤0.01%
+1
New +$12
IPM
5262
Intelligent Protection Management Corp
IPM
$23.9M
$12 ﹤0.01%
+6
New +$12
CREX icon
5263
Creative Realities
CREX
$39.9M
$11 ﹤0.01%
+5
New +$13
DLHC icon
5264
DLH Holdings
DLHC
$78.3M
$11 ﹤0.01%
2
-1,242
-100% -$7K
FLNT
5265
Fluent
FLNT
$106M
$11 ﹤0.01%
+5
New +$11
IPW icon
5266
iPower
IPW
$1.08M
0
AKA icon
5267
a.k.a. Brands
AKA
$119M
$10 ﹤0.01%
1
CVV icon
5268
CVD Equipment Corp
CVV
$43.3M
$10 ﹤0.01%
+3
New +$10
LSTA icon
5269
Lisata Therapeutics
LSTA
$9.93M
$10 ﹤0.01%
4
BSBK icon
5270
Bogota Financial
BSBK
$114M
$9 ﹤0.01%
+1
New +$9
LANV.WS
5271
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$9 ﹤0.01%
500
QNCX icon
5272
Quince Therapeutics
QNCX
$21.5M
0
TOMZ icon
5273
TOMI Environmental Solutions
TOMZ
$11.7M
$9 ﹤0.01%
+3
New +$9
ZURA icon
5274
Zura Bio
ZURA
$504M
$9 ﹤0.01%
2
BDSX icon
5275
Biodesix
BDSX
$211M
$8 ﹤0.01%
1
-8
-89% -$62

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.